South Korea considers Poison Pills

13 November 2009

Sarah Wilson

Latest News

shareholder meetings and proxy voting

Minerva Proxy Update

Exon logo

ExxonMobil’s Texas redomicile passes with high dissent

SEC logo

SEC Moves to Unwind Climate Disclosure Rules

SpaceX logo

SpaceX IPO highlights governance risks as Musk consolidates control

AGM, Proxy Season, Shareholder Proposals

Minerva Proxy Update

TISFD Disclosure

What the TISFD draft tells us about where disclosure is heading

Featured Briefings

Australia Proxy Season Review 2025

2026 Proxy Season Preview

Diversity Divergence: Shareholders Steadfast Amid Pervasive Political Posturing

The Korean Justice Ministry stated this week that Korea has 'made hostile M&A attacks easy by removing a ceiling on foreign stock investments, but it has not had any means to prevent hostile M&A'. It has announced public hearings to consider proposals to provide for the use of poison pills. Reuters reported that business groups have called for a clause to allow an acquisition target to issue new shares to designated shareholders at a preset low price, thus diluting the ownership value for a hostile bidder.

Further Reading

South Korea Considers Letting Companies Use Poison Pills

Related Stories

No items found.